Showing results (301-310 of 830) with videos related to
Sort By:
Pageof 83
Pharmacogenetics|August 2, 2003
Deleterious mutations in the flavin-containing monooxygenase 3 (FMO3) gene causing trimethylaminuriaJun Zhang, Quyen Tran, Virginie Lattard, et al.Pharmacogenetics|June 4, 2002
A novel mutant allele of the CYP2A6 gene (CYP2A6*11 ) found in a cancer patient who showed poor metabolic phenotype towards tegafurSatoshi Daigo, Yoshiki Takahashi, Masaki Fujieda, et al.Pharmacogenetics|January 25, 2003
A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivityLijie Yue, Yutaka Saikawa, Kazuhisa Ota, et al.Pharmacogenetics|February 24, 2001
Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French populationM A Loriot, S Rebuissou, M Oscarson, et al.Pharmacogenetics|June 1, 1995
Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1S Ono, T Hatanaka, H Hotta, et al.Pharmacogenetics|April 1, 1995
Cancer genes: single and susceptibility: exposing the differenceN Caporaso, A GoldsteinPharmacogenetics|October 1, 1993
Expression of CYP1A1 and CYP1A2 genes in human liverH Schweikl, J A Taylor, S Kitareewan, et al.Pharmacogenetics|October 1, 1993
Acetylation phenotype and genotype in aboriginal leprosy patients from the north-west region of Western AustraliaK F Ilett, G M Chiswell, R M Spargo, et al.Pharmacogenetics|October 1, 1993
Re-evaluation of the metabolism of carbocisteine in a British white populationW L Gregory, O F James, I Turner, et al.Pharmacogenetics|February 1, 1994
1462V mutation in the human CYP1A1 gene: lack of correlation with either the Msp I 1.9 kb (M2) allele or CYP1A1 inducibility in a three-generation family of east Mediterranean descentP J Wedlund, S Kimura, F J Gonzalez, et al.Pageof 83